A Minimally-Invasive Blood-Derived Biomarker of Oligodendrocyte Cell-Loss in Multiple Sclerosis

EBioMedicine - Netherlands
doi 10.1016/j.ebiom.2016.06.031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Multiple Sclerosis Patient-Derived CSF Induces Transcriptional Changes in Proliferating Oligodendrocyte Progenitors

Multiple Sclerosis
Neurology
2015English

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis

Frontiers in Neurology
Neurology
2019English

New Insights Into Immune Cell-Derived Extracellular Vesicles in Multiple Sclerosis

Frontiers in Neurology
Neurology
2018English

Minimally Invasive Surgical Treatment of Multiple Liver Abscesses

Grekov's Bulletin of Surgery
2017English

Oligodendrocyte Regeneration: Its Significance in Myelin Replacement and Neuroprotection in Multiple Sclerosis

Neuropharmacology
Molecular NeuroscienceCellularPharmacology
2016English

Minimally Invasive Surgery in Sickle Cell Disease.

BMJ
1991English

Sudden Sensorineural Hearing Loss in a Multiple Sclerosis Case

Northern Clinics of Istanbul
2014English

Optic Neuritis and Retinal Ganglion Cell Loss in a Chronic Murine Model of Multiple Sclerosis

Frontiers in Neurology
Neurology
2011English

Retinal Imaging With Optical Coherence Tomography: A Biomarker in Multiple Sclerosis?

Eye and Brain
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy